Loading...
Market
What will be the change in CVS Caremark's stock price by August 31, 2024?
2
Resolution / Starting Odds
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Stock market data from financial news sources
Story
CVS Caremark to Pay $45 Million Settlement to Illinois Over Drug Rebates via Subsidiary Zinc
Jul 24, 2024, 10:39 AM
CVS Caremark has agreed to pay at least $45 million to the state of Illinois to settle allegations that it failed to pass drug rebates through to the state during a recent four-year period. The settlement follows an investigation by the Illinois Attorney General, which found that CVS Caremark, through its subsidiary Zinc, inappropriately pocketed drug rebates using a rebate aggregator. This settlement is expected to add to the increasing scrutiny of pharmacy benefit managers (PBMs) and their role in the pharmaceutical pricing system.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Higher • 25%
Lower • 25%
Unchanged (+/- 5%) • 25%
Other • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Yes • 50%
No • 50%
Outperforms Walgreens • 25%
Underperforms Walgreens • 25%
Outperforms Cigna • 25%
Underperforms Cigna • 25%
Increase by more than 10% • 25%
Decrease by more than 10% • 25%
No significant change • 25%
Other • 25%
Trust significantly improves • 25%
Trust slightly improves • 25%
Trust remains the same • 25%
Trust declines • 25%
Revenue increases • 25%
Revenue decreases • 25%
Net income increases • 25%
Net income decreases • 25%
Outperform • 25%
Match • 25%
Underperform • 25%
Significantly Underperform • 25%